These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16557150

  • 41. Glycogen synthase kinase 3 regulates IL-1β mediated iNOS expression in hepatocytes by down-regulating c-Jun.
    Lakshmanan J, Zhang B, Nweze IC, Du Y, Harbrecht BG.
    J Cell Biochem; 2015 Jan; 116(1):133-41. PubMed ID: 25160751
    [Abstract] [Full Text] [Related]

  • 42. GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes.
    Evenson AR, Fareed MU, Menconi MJ, Mitchell JC, Hasselgren PO.
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2226-38. PubMed ID: 16051512
    [Abstract] [Full Text] [Related]

  • 43. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma.
    Cuzzocrea S, Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Collin M, Esposito E, Bramanti P, Thiemermann C.
    J Pharmacol Exp Ther; 2006 Jul; 318(1):79-89. PubMed ID: 16601144
    [Abstract] [Full Text] [Related]

  • 44. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
    Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, Xing L.
    Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
    [Abstract] [Full Text] [Related]

  • 45. Protective Effects of Kaempferol against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart via Antioxidant Activity and Inhibition of Glycogen Synthase Kinase-3β.
    Zhou M, Ren H, Han J, Wang W, Zheng Q, Wang D.
    Oxid Med Cell Longev; 2015 Aug; 2015():481405. PubMed ID: 26265983
    [Abstract] [Full Text] [Related]

  • 46. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
    Chen H, Yang S, Yang Z, Ma L, Jiang D, Mao J, Jiao B, Cai Z.
    J Cell Biochem; 2007 Dec 01; 102(5):1281-9. PubMed ID: 17427960
    [Abstract] [Full Text] [Related]

  • 47. Role of glycogen synthase kinase 3β in protective effect of propofol against hepatic ischemia-reperfusion injury.
    Zhao G, Ma H, Shen X, Xu GF, Zhu YL, Chen B, Tie R, Qu P, Lv Y, Zhang H, Yu J.
    J Surg Res; 2013 Nov 01; 185(1):388-98. PubMed ID: 23743186
    [Abstract] [Full Text] [Related]

  • 48. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
    Kim SD, Yang SI, Kim HC, Shin CY, Ko KH.
    Brain Res; 2007 Dec 01; 1186():12-20. PubMed ID: 17996850
    [Abstract] [Full Text] [Related]

  • 49. Controlling the cytokine storm by insulin: glycogen synthase kinase-3 as a target in systemic inflammation.
    Mühl H, Pfeilschifter J.
    Crit Care Med; 2006 May 01; 34(5):1567-9. PubMed ID: 16633265
    [No Abstract] [Full Text] [Related]

  • 50. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
    Jensen J, Brennesvik EO, Lai YC, Shepherd PR.
    Cell Signal; 2007 Jan 01; 19(1):204-10. PubMed ID: 16934435
    [Abstract] [Full Text] [Related]

  • 51. GSK-3β inhibitor TDZD-8 prevents reduction of aquaporin-1 expression via activating autophagy under renal ischemia reperfusion injury.
    Liu Q, Kong Y, Guo X, Liang B, Xie H, Hu S, Han M, Zhao X, Feng P, Lyu Q, Dong W, Liang X, Wang W, Li C.
    FASEB J; 2021 Aug 01; 35(8):e21809. PubMed ID: 34314052
    [Abstract] [Full Text] [Related]

  • 52. S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β.
    Deng H, Zhang N, Wang Y, Chen J, Shen J, Wang Z, Xu R, Zhang J, Song D, Li D.
    Exp Cell Res; 2012 Dec 10; 318(20):2592-603. PubMed ID: 22975730
    [Abstract] [Full Text] [Related]

  • 53. Insulin treatment of diabetic rats reduces cardiac function in a lipopolysaccharide-induced systemic inflammation model.
    Hagiwara S, Iwasaka H, Kudo K, Hasegawa A, Kusaka J, Uchida T, Noguchi T.
    J Surg Res; 2011 Nov 10; 171(1):251-8. PubMed ID: 20638685
    [Abstract] [Full Text] [Related]

  • 54. Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis.
    Choi SE, Kang Y, Jang HJ, Shin HC, Kim HE, Kim HS, Kim HJ, Kim DJ, Lee KW.
    J Vasc Res; 2007 Nov 10; 44(5):365-74. PubMed ID: 17483602
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.
    Patel NS, Nandra KK, Brines M, Collino M, Wong WF, Kapoor A, Benetti E, Goh FY, Fantozzi R, Cerami A, Thiemermann C.
    Mol Med; 2011 Nov 10; 17(9-10):883-92. PubMed ID: 21607291
    [Abstract] [Full Text] [Related]

  • 57. Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes.
    Kanemaki T, Kitade H, Kaibori M, Sakitani K, Hiramatsu Y, Kamiyama Y, Ito S, Okumura T.
    Hepatology; 1998 May 10; 27(5):1296-303. PubMed ID: 9581683
    [Abstract] [Full Text] [Related]

  • 58. Glycogen synthase kinase-3beta inhibition attenuates the development of bleomycin-induced lung injury.
    Cuzzocrea S, Genovese T, Mazzon E, Esposito E, Muià C, Abdelrahman M, Di Paola R, Bramanti P, Thiemermann C.
    Int J Immunopathol Pharmacol; 2007 May 10; 20(3):619-30. PubMed ID: 17880775
    [Abstract] [Full Text] [Related]

  • 59. Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock.
    McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, Harwood S, Plevin R, Chatterjee PK, Yaqoob MM, Thiemermann C.
    FASEB J; 2001 Jan 10; 15(1):171-186. PubMed ID: 11149905
    [Abstract] [Full Text] [Related]

  • 60. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
    Collin M, Rossi A, Cuzzocrea S, Patel NS, Di Paola R, Hadley J, Collino M, Sautebin L, Thiemermann C.
    J Leukoc Biol; 2004 Nov 10; 76(5):961-70. PubMed ID: 15328337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.